Digestive Diseases

Main lines of research

Experimental research

  • Experimental rat model of cirrhosis and ascites.
  • Mechanisms and prevention of bacterial translocation in rats with cirrhosis.
  • Experimental model of spontaneous and induced bacterial peritonitis: physiopathology and treatment.
  • MiRNAs expression profile in inflammatory bowel disease after stimulation with toll-like receptor ligands.

Clinical investigation

  • Physiopathology, diagnosis, treatment and prevention of bacterial infections, ascites and hepatorenal syndrome in cirrhosis.
  • Diagnosis and treatment of hepatic encephalopathy in cirrhosis.
  • Cognitive impairment, falls and quality of life in patients with cirrhosis.
  • Physiopathology, diagnosis, treatment and prevention of digestive haemorrhage due to portal hypertension of non varicose origin.
  • Diagnosis and treatment of chronic hepatitis B and C.
  • Diagnosis and treatment of hepatocarcinoma.
  • Physiopathology, diagnosis and treatment of intestinal inflammatory disease (inflammatory bowel disease).
  • Diagnosis and treatment in advanced gastrointestinal endoscopy.
  • Diagnosis and treatment of acute pancreatitis.
  • Prevention of acute post-ERCP pancreatitis.
  • Chronic pancreatitis and pancreatic neoplasms: molecular studies, early detection and treatment.


  • Consolidate the CIBEREHD research group by studying complications in cirrhosis.
  • Expand the hepatology research lab and develop new research.
  • Consolidate the portal hypertension research group.
  • Consolidate the pancreatic illness research line.
  • Consolidate the inflammatory bowel disease research line.
  • Consolidate the polyps and colon cancer research line.
  • Develop a digestive endoscopy research line.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information